Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check3 days agoChange DetectedA new revision tag v3.5.4 was added to the page and the previous tag v3.5.3 was removed, indicating a standard version update rather than a change to the study data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedUpdated the displayed software version label for the study details page from “Revision: v3.5.2” to “Revision: v3.5.3.”SummaryDifference0.1%

- Check31 days agoChange DetectedRevision: v3.5.2 replaces the previous Revision: v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check96 days agoChange DetectedAn update to the site revision indicator from v3.4.1 to v3.4.2 was applied; no changes to study content, eligibility criteria, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.